NDTVCenter·
Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
Read at NDTV →
Business · 1 sources covering this
Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/9dcf2e941a1d8191a61441c640929c695a529e5e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%"></iframe>
